Emily Peterson Alva's most recent trade in Amneal Pharmaceuticals Inc - Ordinary Shares - Class A was a trade of 40,258 Class A Common Stock done . Disclosure was reported to the exchange on May 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Amneal Pharmaceuticals Inc... | Emily Peterson Alva | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2025 | 40,258 | 211,029 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharmaceuticals Inc... | Emily Peterson Alva | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2025 | 40,258 | 0 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | Emily Peterson Alva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2025 | 34,819 | 34,819 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | Emily Peterson Alva | Director | Sale of securities on an exchange or to another person at price $ 8.90 per share. | 05 Mar 2025 | 80,000 | 170,771 (0%) | 0% | 8.9 | 712,000 | Class A Common Stock |
| Alkermes plc | Emily Peterson Alva | Director | 29 Jun 2024 | 6,104 | 28,767 (0%) | 0% | - | Ordinary Shares | ||
| Alkermes plc | Emily Peterson Alva | Director | 29 Jun 2024 | 6,104 | 0 | - | - | Restricted Stock Unit Award | ||
| Alkermes plc | Emily Peterson Alva | Director | 29 Jun 2024 | 1,465 | 27,302 (0%) | 0% | 24.1 | 35,307 | Ordinary Shares | |
| Alkermes plc | Emily Peterson Alva | Director | 09 Jun 2024 | 3,871 | 0 | - | - | Restricted Stock Unit Award | ||
| Alkermes plc | Emily Peterson Alva | Director | 09 Jun 2024 | 3,871 | 23,593 (0%) | 0% | - | Ordinary Shares | ||
| Alkermes plc | Emily Peterson Alva | Director | 09 Jun 2024 | 930 | 22,663 (0%) | 0% | 23.9 | 22,236 | Ordinary Shares | |
| Alkermes plc | Emily Peterson Alva | Director | 31 May 2024 | 17,492 | 17,492 | - | - | Non Qualified Stock Option (Right to Buy) | ||
| Alkermes plc | Emily Peterson Alva | Director | 31 May 2024 | 8,013 | 8,013 | - | - | Restricted Stock Unit Award | ||
| Alkermes plc | Emily Peterson Alva | Director | 31 May 2024 | 455 | 23,214 | - | - | Non Qualified Stock Option (Right to Buy) | ||
| Alkermes plc | Emily Peterson Alva | Director | 31 May 2024 | 313 | 15,990 | - | - | Non Qualified Stock Option (Right to Buy) | ||
| Alkermes plc | Emily Peterson Alva | Director | 31 May 2024 | 254 | 12,986 | - | - | Non Qualified Stock Option (Right to Buy) | ||
| Alkermes plc | Emily Peterson Alva | Director | 31 May 2024 | 231 | 11,785 | - | - | Non Qualified Stock Option (Right to Buy) | ||
| Alkermes plc | Emily Peterson Alva | Director | 31 May 2024 | 119 | 6,104 | - | - | Restricted Stock Unit Award | ||
| Alkermes plc | Emily Peterson Alva | Director | 31 May 2024 | 75 | 3,871 | - | - | Restricted Stock Unit Award | ||
| Alkermes plc | Emily Peterson Alva | Director | 31 May 2024 | 22 | 1,137 | - | - | Non Qualified Stock Option (Right to Buy) | ||
| Amneal Pharmaceuticals Inc... | Emily Peterson Alva | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2024 | 76,453 | 0 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | Emily Peterson Alva | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2024 | 76,453 | 250,771 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharmaceuticals Inc... | Emily Peterson Alva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2024 | 40,258 | 40,258 | - | - | Restricted Stock Units | |
| Alkermes plc | Emily Peterson Alva | Director | 07 Jul 2023 | 5,957 | 21,152 (0%) | 0% | - | Ordinary Shares | ||
| Alkermes plc | Emily Peterson Alva | Director | 07 Jul 2023 | 5,957 | 0 | - | - | Restricted Stock Unit Award | ||
| Alkermes plc | Emily Peterson Alva | Director | 07 Jul 2023 | 1,430 | 19,722 (0%) | 0% | 29.9 | 42,728 | Ordinary Shares | |
| Alkermes plc | Emily Peterson Alva | Director | 29 Jun 2023 | 12,732 | 12,732 | - | - | Non Qualified Stock Option (Right to Buy) | ||
| Alkermes plc | Emily Peterson Alva | Director | 29 Jun 2023 | 5,985 | 5,985 | - | - | Restricted Stock Unit Award | ||
| Alkermes plc | Emily Peterson Alva | Director | 09 Jun 2023 | 3,795 | 16,106 (0%) | 0% | - | Ordinary Shares | ||
| Alkermes plc | Emily Peterson Alva | Director | 09 Jun 2023 | 3,795 | 3,796 | - | - | Restricted Stock Unit Award | ||
| Alkermes plc | Emily Peterson Alva | Director | 09 Jun 2023 | 911 | 15,195 (0%) | 0% | 31.1 | 28,359 | Ordinary Shares | |
| Amneal Pharmaceuticals Inc... | Emily Peterson Alva | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2023 | 80,128 | 0 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | Emily Peterson Alva | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2023 | 80,128 | 174,318 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharmaceuticals Inc... | Emily Peterson Alva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2023 | 76,453 | 76,453 | - | - | Restricted Stock Units | |
| Alkermes plc | Emily Peterson Alva | Director | 07 Jul 2022 | 11,554 | 11,554 | - | - | Non Qualified Stock Option (Right to Buy) | ||
| Alkermes plc | Emily Peterson Alva | Director | 07 Jul 2022 | 5,957 | 5,957 | - | - | Restricted Stock Unit Award | ||
| Alkermes plc | Emily Peterson Alva | Director | 14 Jun 2022 | 7,585 | 13,216 (0%) | 0% | - | Ordinary Shares | ||
| Alkermes plc | Emily Peterson Alva | Director | 14 Jun 2022 | 7,585 | 0 | - | - | Restricted Stock Unit Award | ||
| Alkermes plc | Emily Peterson Alva | Director | 14 Jun 2022 | 905 | 12,311 (0%) | 0% | 27.2 | 24,607 | Ordinary Shares | |
| Alkermes plc | Emily Peterson Alva | Director | 09 Jun 2022 | 3,796 | 5,935 (0%) | 0% | - | Ordinary Shares | ||
| Alkermes plc | Emily Peterson Alva | Director | 09 Jun 2022 | 3,796 | 7,591 | - | - | Restricted Stock Unit Award | ||
| Alkermes plc | Emily Peterson Alva | Director | 09 Jun 2022 | 532 | 0 | - | - | Restricted Stock Unit Award | ||
| Alkermes plc | Emily Peterson Alva | Director | 09 Jun 2022 | 532 | 2,182 (0%) | 0% | - | Ordinary Shares | ||
| Alkermes plc | Emily Peterson Alva | Director | 09 Jun 2022 | 304 | 5,631 (0%) | 0% | 28.1 | 8,552 | Ordinary Shares | |
| Alkermes plc | Emily Peterson Alva | Director | 09 Jun 2022 | 43 | 2,139 (0%) | 0% | 28.1 | 1,210 | Ordinary Shares | |
| Amneal Pharmaceuticals Inc... | Emily Peterson Alva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2022 | 80,128 | 80,128 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | Emily Peterson Alva | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2022 | 35,406 | 0 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | Emily Peterson Alva | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2022 | 35,406 | 94,190 (0%) | 0% | - | Class A Common Stock | |
| Alkermes plc | Emily Peterson Alva | Director | 23 Aug 2021 | 1,650 | 1,650 (0%) | 0% | 30.2 | 49,860 | Ordinary Shares | |
| Alkermes plc | Emily Peterson Alva | Director | 09 Jun 2021 | 22,759 | 22,759 | - | - | Non Qualified Stock Option (Right to Buy) | ||
| Alkermes plc | Emily Peterson Alva | Director | 09 Jun 2021 | 11,387 | 11,387 | - | - | Restricted Stock Unit Award | ||
| Alkermes plc | Emily Peterson Alva | Director | 09 Jun 2021 | 1,115 | 1,115 | - | - | Non Qualified Stock Option (Right to Buy) | ||
| Alkermes plc | Emily Peterson Alva | Director | 09 Jun 2021 | 532 | 532 | - | - | Restricted Stock Unit Award | ||
| Amneal Pharmaceuticals Inc... | Emily Peterson Alva | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2021 | 46,218 | 0 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | Emily Peterson Alva | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2021 | 46,218 | 58,784 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharmaceuticals Inc... | Emily Peterson Alva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2021 | 35,406 | 35,406 | - | - | Restricted Stock Units |